Chapter 19 Agents Affecting Blood Clotting. Copyright 2007 Thomson Delmar Learning, a division of...

Post on 15-Dec-2015

223 views 3 download

Tags:

transcript

Chapter 19

Agents Affecting Blood Clotting

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 2

Blood Clotting

Thromboemboli Cause many deaths per year

Anticoagulants Prevent the formation of coagulants

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 3

Anticoagulant Agents

Inhibit the formation of clots Heparin

Found in mast cells

Action Inhibit the clotting process

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 4

Heparin

Heparin action Indirectly interferes with the conversion of

prothrombin to thrombin The deficiency of thrombin prevents the

conversion of fibrinogen to fibrin

(continues)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 5

Heparin

Destroyed if given orally Administered via IV infusion

No intramuscular injections Administered subcutaneously

Longer acting form No intramuscular injections

(continued)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 6

Heparin: Side Effects

Hemorrhage Allergy Antidote

Protamine sulfate Caution

Do not administer to clients with coagulation disorders

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 7

Low Molecular Weight Anticoagulant

Related to heparin Minor risk for bleeding

Does not affect the action of thrombin in the clotting cascade

(continues)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 8

Low Molecular Weight Anticoagulant

Example: enoxaparim (Lovenox)

(continued)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 9

Oral Anticoagulants

Warfarin (Coumadin) Inhibits blood clotting by interfering with

the synthesis of vitamin K-dependent clotting factors

Close client monitoring Dosage is individualized International normalized ratio

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 10

Antiplatelet Agents

Action: inhibit the aggregation of platelets

Treat clients who have had cerebrovascular accidents or myocardial infarctions

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 11

Antiplatelets

Examples Aspirin Abciximab (ReoPro) Clopidogrel bisulfate (Plavix)

Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved.

19 - 12

Thrombolytic Agents

Action Convert plasminogen to enzyme

fibrinolysin; fibrinolysin dissolves clots Example

Streptokinase (IV) Caution

Hemorrhage